These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35590395)

  • 1. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
    Greenham L; Bennett PN; Dansie K; Viecelli AK; Jesudason S; Mister R; Smyth B; Westall P; Herzog S; Brown C; Handke W; Palmer SC; Caskey FJ; Couchoud C; Simes J; McDonald SP; Morton RL
    Trials; 2022 May; 23(1):419. PubMed ID: 35590395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
    Agarwal N; Shah KK; Dansie K; Bennett PN; Greenham L; Brown C; Smyth B; McDonald S; Jesudason S; Viecelli AK; Morton RL;
    BMC Nephrol; 2023 Nov; 24(1):345. PubMed ID: 37993776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring WIth Feedback Trial (SWIFT) pilot: protocol for a qualitative study in Australia.
    Duncanson E; Bennett PN; Viecelli A; Dansie K; Handke W; Tong A; Palmer S; Jesudason S; McDonald SP; Morton RL;
    BMJ Open; 2020 Nov; 10(11):e039014. PubMed ID: 33158824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study.
    Morton RL; Lioufas N; Dansie K; Palmer SC; Jose MD; Raj R; Salmon A; Sypek M; Tong A; Ludlow M; Boudville N; McDonald S
    Nephrology (Carlton); 2020 Jan; 25(1):14-21. PubMed ID: 30838732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
    Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE;
    Trials; 2023 May; 24(1):365. PubMed ID: 37254217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.
    Chow JSF; Boudville N; Cho Y; Palmer S; Pascoe EM; Hawley CM; Reidlinger DM; Hickey LE; Stastny R; Valks A; Vergara L; Movva R; Kiriwandeniya C; Candler H; Mihala G; Buisman B; Equinox KL; Figueiredo AE; Fuge T; Howard K; Howell M; Jaure A; Jose MD; Lee A; Miguel SS; Moodie JA; Nguyen TT; Pinlac G; Reynolds A; Saweirs WWM; Steiner-Lim GZ; TeWhare B; Tomlins M; Upjohn M; Voss D; Walker RC; Wilson J; Johnson DW
    Trials; 2023 Nov; 24(1):730. PubMed ID: 37964367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of Cooled HaEmodialysis on Cognitive function in patients suffering with end-stage KidnEy Disease (E-CHECKED): feasibility randomised control trial protocol.
    Dasgupta I; Odudu A; Baharani J; Fergusson N; Griffiths H; Harrison J; Maruff P; Thomas GN; Woodhall G; Youseff S; Tadros G
    Trials; 2020 Sep; 21(1):820. PubMed ID: 32998761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol.
    Johnson JA; Al Sayah F; Buzinski R; Corradetti B; Davison SN; Elliott MJ; Klarenbach S; Manns B; Schick-Makaroff K; Short H; Thomas C; Walsh M
    BMC Health Serv Res; 2020 Aug; 20(1):731. PubMed ID: 32778102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial.
    Luckett T; Phillips J; Agar M; Lam L; Davidson PM; McCaffrey N; Boyle F; Shaw T; Currow DC; Read A; Hosie A; Lovell M
    BMC Health Serv Res; 2018 Jul; 18(1):558. PubMed ID: 30012122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial.
    Hull KL; Bramham K; Brookes CL; Cluley V; Conefrey C; Cooper NJ; Eborall H; Fotheringham J; Graham-Brown MPM; Gray LJ; Mark PB; Mitra S; Murphy GJ; Quann N; Rooshenas L; Warren M; Burton JO
    Trials; 2023 Aug; 24(1):522. PubMed ID: 37573352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis: A cluster randomized controlled trial protocol.
    Milazi M; Douglas C; Bonner A
    J Adv Nurs; 2018 Oct; 74(10):2431-2441. PubMed ID: 29943430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol.
    Gill JK; Pucci M; Samudio A; Ahmed T; Siddiqui R; Edwards N; Marticorena RM; Donnelly S; Lok C; Wentlandt K; Wolofsky K; Mucsi I
    BMJ Open; 2024 Jan; 14(1):e080712. PubMed ID: 38296283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the SUCCESS Health Literacy App for Australian Adults With Chronic Kidney Disease: Protocol for a Pragmatic Randomized Controlled Trial.
    Isautier J; Webster AC; Lambert K; Shepherd HL; McCaffery K; Sud K; Kim J; Liu N; De La Mata N; Raihana S; Kelly PJ; Muscat DM;
    JMIR Res Protoc; 2022 Aug; 11(8):e39909. PubMed ID: 36044265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol.
    Dingwall KM; Nagel T; Hughes JT; Kavanagh DJ; Cass A; Howard K; Sweet M; Brown S; Sajiv C; Majoni SW
    BMC Psychol; 2019 Jan; 7(1):2. PubMed ID: 30621791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.
    Knowles SR; Ski CF; Langham R; O'Flaherty E; Thompson DR; Rossell SL; Moore G; Hsueh YS; Castle DJ
    Trials; 2016 Sep; 17(1):447. PubMed ID: 27612446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.
    Friedli K; Almond M; Day C; Chilcot J; Gane Mda S; Davenport A; Guirguis A; Fineberg N; Spencer B; Wellsted D; Farrington K
    BMC Nephrol; 2015 Oct; 16():172. PubMed ID: 26503099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
    Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
    Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.